Pharmaceutical Manufacturing & Formulation

The contract pertains to the manufacturing of Ketorolac Tromethamine Injection, USP 15 mg/mL, in prefilled syringes, adhering strictly to current Good Manufacturing Practices, FDA regulations, and USP standards. The product must be produced in a certified facility with full compliance to ensure safety, potency, and consistency, with all processes subject to rigorous quality control and documentation requirements. The scope includes end-to-end production from active pharmaceutical ingredient handling through final packaging, with prefilled syringes meeting specific sterility, particulate, and dosage accuracy specifications outlined by regulatory authorities. This is a subcontract issued by the Department of Defense under the Medical Supply Chain Pharm FSA, with performance required at Fort Bragg, North Carolina, 28310. The solicitation was posted on July 26, 2026, and responses are due by August 3, 2026, indicating a tight turnaround for technical and compliance submissions. The NAICS code 325412 confirms the classification under Pharmaceutical and Botanical Product Manufacturing, and the contract is part of the DoD’s effort to secure a reliable, compliant supply of critical medications for military medical operations. All parties must be prepared to demonstrate capacity for scale, regulatory adherence, and on-time delivery under stringent federal procurement guidelines.